FAHR Syndrome: Case Report

Year 2016, Volume: 69 Issue: 1, 37 - 39, 03.06.2016

Buket Tuğan Yıldız

Abstract

Fahr Syndrome revelead accumulation of calcium and various minerals in basal ganglia, cerebellum and centrum semiovale bilaterally and symmetrical. The most common clinical presentations are parkinsonism, chorea, tremor, dystonia, cognitive disorders. This patient is referred to policlinic with complaint of only headache, whose hypocalsemia treatment started early. Fahr Syndrome should be considered in etiology of patient with headache, especially if there are hypocalcemia symptoms accompany to the headache, serum calcium levels and imaging should be wanted.

Keywords

Fahr Syndrome , Headache , 􀄝ntracranial Calsification

Ethical Statement

-

Supporting Institution

-

Project Number

-

Thanks

-

FAHR Sendromu: Olgu Sunumu

Abstract

Fahr sendromu, bilateral ve simetrik olarak bazal gangliyonlar, serebellum ve sentrum semiovaleye kalsiyum ve çeşitli minerallerin birikimi ile ortaya çıkar. En sık görülen klinik prezentasyonu parkinsonizm, kore, tremor, distoni, kognitif bozukluklardır. Bu olgu sadece baş ağrısı şikayetiyle polikliniğe başvuran, erken dönemde hipokalsemi tedavisi başlanan bir hasta. Baş ağrısı olan hastalarda etyolojide Fahr sendromu akla gelmeli, özellikle baş ağrısına eşlik eden hipokalsemi semptomları varsa kan kalsiyum düzeyi ve görüntüleme mutlaka istenmelidir.

Keywords

Fahr Sendromu , Ba􀄹 A􀃾rs , ntrakranial Kalsifikasyon

Project Number

-

References

• 1. Fahr T. Von. Idiopathische verkalkung der hirngefasse. Zentrabl. Allg. Pathol, 1930; 50:129-133.
• 2. Kobari M, Nogawa S. Familial idiopathic brain calcifications with autosomal dominant inheritance. Neurology, 1997; 48:645-649.
• 3. Scotti G, Scialfa G. MR imaging in Fahr disease. J Comput Assist Tomogr 1985; 9:790-792.
• 4. Windect R, Menken U. Basal ganglia calcification in pseudohypoparathyroidism type II. Clin Endocrinol 1981; 15:57-639.
• 5. Beall SS, Patent BM. Abnormal systemic metabolism of iron, porphyrin and calcium in Fahr”s syndrome. Ann Neurol 1989; 26:569-575.
• 6. Esen R, Soyoral Y. U, Bora A. ve ark. Fahr Sendromu; iki Olgu Sunumu. Van Tıp Dergisi, 2010; 17: 96-99.
• 7. Manyam B. V, “What is and what is not ’Fahr’s disease’ ”, Parkinsonism and Related Disorders, 2005; 11: 73-80.
• 8. Tuglu D, Yuvanç E, Bal F. ve ark. Fahr Syndrome Unknown Complication: Overactive Bladder. Case Reports in Urology, 2014, Article ID 939268, 1-2.
• 9. Shakibai SV, Johnson JP, Bourgeois JA. Paranoid delusions and cognitive impairment suggesting Fahr’s disease. Psychosomatics 2005;46:569-572.
• 10. Lazar M, Ion DA, Streinu- Cercel A, Badarau Al. Fahr’s syndrome: diagnosis issues in patients with unknown family history of disease. Rom J Morphol Embryo 2009;50:425-428.
• 11. Yürekli A. V, Gündoğar D, Özcankaya R, Koyuncuoğlu HR, Kutluhan S. Nadir bir demans sebebi: fahr hastalığı S.D.Ü. Tıp Fak. Derg 2007;14:32-34.
• 12. Koç E, Tunç S. Atipik klinik bulgular ile seyreden Fahr hastalığı: iki olgu sunumu. Klinik ve D S. eneysel Araştırmalar Dergisi 2010; 1
• 13. Avrahami E, Cohn DF, Feibel M, Tadmor R. MRI demonstration and CT correlation of the brain in patients with idioidiopathic intracerebral calcification. J Neurol 1994;241:381-384.
• 14. Kaçar E. Nadir Görülen Bir 􀃹ntrakranial Kalsifikasyon Olgusu: FAHR Sendromu. The Medical Journal of Kocatepe 2010;11: 31-33.
• 15. Cartier L, Passig C, Gormaz A, Lopez J. Neurophysiologycal and Neurophysiologycal features of Fahr’s Disease. Rev Med Chil 2002; 130: 1383-1390.
• 16. Baydar C, Güneş H N, Yoldaş T K, Yılmaz A. Gerilim Tipi Baş Ağrısı ve Fahr Hastallığı Birlikteliği: Ankara Med J 2014; 14: 68-70.
• 17. Uslu Fİ, Hanağası HA. Hipoparatroidizm ve bilateral striopallidodentat kalsinozis. Nöropsikiyatri Arşivi 2006;43:31-36.
• 18. Sambrook MA, Hill LF. Cerebrospinal fluid absorption in primary hypoparathyroidism. J Neurol Neurosurg Psychiatry 1977;40:1015-7.